Anemia Effects and Management

20th Annual NATA Symposium

20th Annual NATA Symposium, Berlin 2019The 20th Annual NATA Symposium on Patient Blood Management, Haemostasis and Thrombosis took place on April 4-5, 2019 in Berlin, Germany.

This year, 580 delegates from 38 countries participated in the symposium and there was a record local attendance of 167 attendees from Portugal.

Download the NATA Conference App, “NATA Forum”, on the App Store or the Play Store to access presentation webcasts.

The Abstract Book can be downloaded here.

Please click on the link below for more information
20th Annual Symposium General Information

News from the Industry: Monofer – a new therapeutic option for iron-deficiency anemia

Monofer® (iron isomaltoside 1000) is an innovative intravenous iron preparation that allows high-dose iron treatment for patients with iron-deficiency anemia. Monofer is indicated for the treatment of iron-deficiency anemia when oral iron preparations are ineffective or cannot be used, or when there is a clinical need to deliver iron rapidly.
For more information on Monofer, read the full article.

Read more on this


From the Literature

Oct 22, 2018

Published: Sep 2017

Boer C, Meesters MI, Milojevic M, et al.

2017 EACTS/EACTA Guidelines on patient blood management for adult cardiac surgery.
J Cardiothorac Vasc Anesth 2017; Sep 30 [Epub ahead of print].

#

NATA REVIEW:
There is growing evidence that patient blood management (PBM) is becoming "standard of care" in major surgery...
REVIEW by:
P. Van der Linden

Published: Mar 2017

White MC, Longstaff L, Lai PS

Effect of pre-operative anaemia on post-operative complications in low-resource settings.
World J Surg 2017;41:644-649.

#

NATA REVIEW:
This study reports on the impact of anaemia upon surgical outcome by retrospectively analysing a cohort of 2073 patients...
REVIEW by:
B. Clevenger

Published: Mar 2017

Ad N, Holmes SD, Patel J, et al.

The impact of a multidisciplinary blood conservation protocol on patient outcomes and cost after cardiac surgery.
J Thorac Cardiovasc Surg 2017;153:597-605.

#

NATA REVIEW:
This before-and-after study confirms that a standardised intraoperative blood conservation programme including...
REVIEW by:
P. Van der Linden

Published: Jan 2017

French CJ, Glassford NJ, Gantner D, et al.

Erythropoiesis-stimulating agents in critically ill trauma patients: a systematic review and meta-analysis.
Ann Surg 2017;265:54-62.

#

NATA REVIEW:
In this paper, French and co-authors address the ongoing debate on the use of erythropoietin (EPO) in critically...
REVIEW by:
C. So-Osman

Published: Nov 2016

von Heymann C, Kaufner L, Sander M, et al.

Does the severity of preoperative anemia or blood transfusion have a stronger impact on long-term survival after cardiac surgery?
J Thorac Cardiovasc Surg 2016;152:1412-1420.

#

NATA REVIEW:
In this study, von Heymann and colleagues describe the effects of different degrees of preoperative anaemia and/or...
REVIEW by:
J. Meier

Published: Oct 2016

Voorn VM, van der Hout A, So-Osman C, et al.

Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty.
Vox Sang 2016;111:219-225.

#

NATA REVIEW:
The authors conducted a systematic review and meta-analysis to assess the benefits, the safety and the costs...
REVIEW by:
J.-F. Hardy